205 related articles for article (PubMed ID: 9769824)
1. Hepatocellular carcinoma: power Doppler US with a contrast agent--preliminary results.
Kim AY; Choi BI; Kim TK; Han JK; Yun EJ; Lee KY; Han MC
Radiology; 1998 Oct; 209(1):135-40. PubMed ID: 9769824
[TBL] [Abstract][Full Text] [Related]
2. Vascularity of hepatocellular carcinoma: assessment with contrast-enhanced second-harmonic versus conventional power Doppler US.
Choi BI; Kim TK; Han JK; Kim AY; Seong CK; Park SJ
Radiology; 2000 Feb; 214(2):381-6. PubMed ID: 10671584
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results.
Choi D; Lim HK; Kim SH; Lee WJ; Jang HJ; Lee JY; Paik SW; Koh KC; Lee JH
Radiology; 2000 Nov; 217(2):558-63. PubMed ID: 11058660
[TBL] [Abstract][Full Text] [Related]
4. Assessment of tumor vascularity in hepatocellular carcinoma: comparison of power Doppler US and color Doppler US.
Lencioni R; Pinto F; Armillotta N; Bartolozzi C
Radiology; 1996 Nov; 201(2):353-8. PubMed ID: 8888222
[TBL] [Abstract][Full Text] [Related]
5. [The correlation between Doppler echography with a contrast medium and CT in the study of a hepatocarcinoma submitted to chemoembolization].
Catalano O; Cusati B; Esposito M; Trivellini V; Lobianco R; Siani A
Radiol Med; 1998 Jun; 95(6):608-13. PubMed ID: 9717543
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation.
Vilana R; Llovet JM; Bianchi L; Sanchez M; Pagés M; Sala M; Gilabert R; Nicolau C; Garcia A; Ayuso C; Bruix J; Bru C;
J Clin Ultrasound; 2003; 31(3):119-28. PubMed ID: 12594796
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma: depiction of tumor parenchymal flow with intermittent harmonic power Doppler US during the early arterial phase in dual-display mode.
Ding H; Kudo M; Onda H; Suetomi Y; Minami Y; Maekawa K
Radiology; 2001 Aug; 220(2):349-56. PubMed ID: 11477236
[TBL] [Abstract][Full Text] [Related]
8. Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: correlation with angiographic findings.
Fujimoto M; Moriyasu F; Nishikawa K; Nada T; Okuma M
AJR Am J Roentgenol; 1994 Nov; 163(5):1099-104. PubMed ID: 7976882
[TBL] [Abstract][Full Text] [Related]
9. Contrast media-enhanced power Doppler sonography for evaluation of hemangiomas and malignant tumors in the liver.
Karabacakoglu A; Karakose S; Cil AS; Kaya A
J Gastroenterol Hepatol; 2003 Jan; 18(1):92-8. PubMed ID: 12519230
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional power Doppler ultrasonography for demonstrating associated arteries of hepatocellular carcinoma.
Liang JD; Yang PM; Liang PC; Huang GT; Sheu JC; Chen DS
J Formos Med Assoc; 2003 Jun; 102(6):367-74. PubMed ID: 12923588
[TBL] [Abstract][Full Text] [Related]
11. [Native and signal-enhanced power Doppler sonography for characterization of liver lesions].
Strunk H; Stuckmann G; Fröhlich E; Textor J; Wilhelm K; Hortling N; Remig J
Rofo; 1998 Apr; 168(4):344-51. PubMed ID: 9589096
[TBL] [Abstract][Full Text] [Related]
12. Vascularization of liver tumors - preliminary results with Coded Harmonic Angio (CHA), phase inversion imaging, 3D power Doppler and contrast medium-enhanced B-flow with second generation contrast agent (Optison).
Jung EM; Kubale R; Jungius KP; Jung W; Lenhart M; Clevert DA
Clin Hemorheol Microcirc; 2006; 34(4):483-97. PubMed ID: 16687788
[TBL] [Abstract][Full Text] [Related]
13. Quantitative comparison of tumor vascularity of hepatocellular carcinoma after intravenous contrast agent: conventional versus harmonic power Doppler US.
Park SH; Kim TK; Lee KH; Kim AY; Choi JI; Han JK; Choi BI
Abdom Imaging; 2001; 26(2):178-83. PubMed ID: 11178696
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effect of transcatheter arterial chemoembolization on hepatocellular carcinoma: evaluation with contrast-enhanced harmonic power Doppler ultrasound.
Cioni D; Lencioni R; Bartolozzi C
Eur Radiol; 2000; 10(10):1570-5. PubMed ID: 11044926
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis.
Fracanzani AL; Burdick L; Borzio M; Roncalli M; Bonelli N; Borzio F; Maraschi A; Fiorelli G; Fargion S
Hepatology; 2001 Dec; 34(6):1109-12. PubMed ID: 11731999
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of sequential imaging of hepatocellular carcinoma by contrast-enhanced power Doppler ultrasonograpy.
Suzuki Y; Fujimoto Y; Hosoki Y; Suzuki M; Sakurai S; Ohhira M; Saito H; Kohgo Y
Eur J Radiol; 2003 Nov; 48(2):214-9. PubMed ID: 14680917
[TBL] [Abstract][Full Text] [Related]
17. Assessment of vascularity in hepatic tumors: comparison of power Doppler sonography and intraarterial CO(2)-enhanced sonography.
Chen RC; Chen WT; Tu HY; Cheng NY; Wang CK; Liao LY; Wang CS; Chen PH
AJR Am J Roentgenol; 2002 Jan; 178(1):67-73. PubMed ID: 11756089
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of SH U 508 A (Levovist) in color Doppler ultrasonography of hepatocellular carcinoma vascularization.
Angeli E; Carpanelli R; Crespi G; Zanello A; Sironi S; Del Maschio A
Radiol Med; 1994 May; 87(5 Suppl 1):24-31. PubMed ID: 8209014
[TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced, wide-band, phase inversion harmonic power Doppler imaging of hepatocellular carcinoma.
Janica J; Serwatka W; Polaków J; Kordecki K; Łebkowska U; Walecki J; Dobrzycki S
Med Sci Monit; 2004 Jun; 10 Suppl 3():32-5. PubMed ID: 16538196
[TBL] [Abstract][Full Text] [Related]
20. Nonpalpable breast lesions: evaluation with power Doppler US and a microbubble contrast agent-initial experience.
Moon WK; Im JG; Noh DY; Han MC
Radiology; 2000 Oct; 217(1):240-6. PubMed ID: 11012451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]